ARTICLE
2 June 2026

Makary Resigns From FDA Commissioner Post

SH
Shook, Hardy & Bacon

Contributor

Shook, Hardy & Bacon has long been recognized as one of the premier litigation firms in the country. For more than a century, the firm has defended companies in their most substantial national and international products liability, mass tort and complex litigation matters.

The firm has leveraged its complex product liability litigation expertise to expand into several other practice areas and advance its mission of “being the best in the world at providing creative and practical solutions at unsurpassed value.” As a result, the firm has built nationally recognized practices in areas such as intellectual property, environmental and toxic tort, employment litigation, commercial litigation, government enforcement and compliance, and public policy.

The U.S. Food and Drug Administration faces a leadership transition as Commissioner Marty Makary steps down amid tensions with the White House, with Deputy Commissioner Kyle Diamantas assuming control in an acting capacity. Will this change in leadership accelerate the agency's food safety reform efforts and chemical assessment initiatives?
United States Food, Drugs, Healthcare, Life Sciences
Shook, Hardy & Bacon are most popular:
  • within Corporate/Commercial Law, Criminal Law and Privacy topic(s)
  • with readers working within the Basic Industries, Environment & Waste Management and Technology industries

U.S. Food and Drug Administration (FDA) Commissioner Marty Makary has announced his resignation from his position following clashes with the White House and heightened scrutiny for agency decisions, according to a Reuters report. His successor is FDA Deputy Commissioner for Food Kyle Diamantas, who will lead the agency in an acting capacity.

Agency IQ by POLITICO reported that Diamantas' leadership may usher in a heightened focus on food chemical safety and other Human Foods Program priorities. "As deputy commissioner for food, Diamantas has been a driving force behind many of the FDA’s recent food reform efforts, including the agency’s newly finalized food chemical postmarket assessment framework and reviews begun on a growing number of substances," the outlet said in its FDA Today: Food newsletter. "His new role at the very top of the agency could potentially add weight to these activities and accelerate them."

Read more stories in Issue 848 of the Food and Beverage Litigation and Regulatory Update ))

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More